VER the past decade, stereotactic radiosurgery has been widely adopted as one of the least invasive treatments for AVMs. To date a large number of clinical studies have been performed in which radiosurgery generally has attained excellent results, with only a 3 to 7% rate of radiation-induced neurological sequelae and a 1.8 to 5% annual risk of latency-interval hemorrhage. 5, 6, 9, 14, 15, 17, 18, 20, 24, 25, 28, 38 The rate of nidus obliteration, a visible goal of treatment, however, varies significantly among the reports and is posited as 65 to 94% at 2 to 5 years. 5, 10, 15, 18, 20, 30, 38 There are several possible reasons for such variability, including different follow-up periods and methods used to demonstrate obliteration. The majority of treated patients described in previous reports were followed up using imaging studies for as long as 3 years, and nidus obliteration rates for longer follow-up periods have not been reported. Therefore, the optimal timing for judging failure of treatment after radiosurgery and considering repeated treatment remains ambiguous. In addition, the diagnosis of nidus obliteration may well be different, depending on the imaging studies used. To address these issues, we performed a retrospective analysis of our 10-year experience with GKS for AVMs, in which the results of each imaging study were carefully examined.
diosurgery as the initial treatment and 115 (28.2%) were referred to our unit for treatment of a residual AVM nidus after the initial treatment. Fifty-four patients (13.2%) had undergone resection, 69 (16.9%) endovascular embolization, and eight patients (2%) both endovascular and surgical procedures. Of the 69 patients who had undergone previous embolization, the embolized part was included in the treatment volume in 57 patients, but not in 12 patients who were treated before CT or MR imaging was introduced to dose planning. For all patients considered to be good candidates for resection, such as those harboring Spetzler-Martin 34 Grade I or II lesions, we primarily recommended resection as the most reasonable treatment, although patients in this study eventually chose radiosurgery.
Radiosurgical Treatment
Patients' heads were placed in a Leksell stereotactic head frame before they underwent stereotactic imaging to obtain precise information on the shape, volume, and three-dimensional coordinates of the AVM nidus. The definition of the nidus and localization of the target were basically obtained using biplanar stereotactic cerebral angiography. In 115 patients who were treated early, dose planning was made using biplanar stereotactic cerebral angiography alone. In 293 patients treated after March 1992, high-resolution thin-slice stereotactic, contrast-enhanced CT or Gd-enhanced MR imaging was used in combination with angiography. Radiosurgery was performed using a 201-source 60 Co Gamma Knife (Elekta Instruments, Inc., Norcross, GA). The dose planning was performed jointly by neurosurgeons and radiation oncologists with the aid of commercially available software (KULA or Leksell GammaPlan; Elekta Instruments, Inc.).
Follow-Up Evaluation
Follow-up clinical examinations were performed at our hospital or elsewhere by referring physicians. Computerized tomography or MR imaging studies were performed every 6 months. Cerebral angiography was recommended at 3 years after radiosurgery, but was performed earlier in patients whose AVMs had disappeared on CT or MR imaging. On angiography nidus obliteration was defined as the disappearance of the nidus itself and early venous filling indicating a remaining arteriovenous shunt. When examined with CT or MR imaging, disappearance of the AVM nidus was defined as the disappearance of enhancement of the nidus and draining vessels on CT scans or the absence of flow-void signal abnormalities on MR imaging. Imaging studies were assessed by neuroradiologists and neurosurgeons independently.
Twenty-two patients underwent a second radiosurgical procedure. Three of these patients underwent the second procedure sooner than 3 years after the first one (16, 19 , and 34 months) because their follow-up angiograms disclosed recanalization of previously embolized portions of the AVM. An additional 19 patients underwent a second procedure longer than 3 years after the first one (37-126 months, median 49 months). In this study, follow-up periods were ended at the time of the second radiosurgery and follow-up data obtained after that time were not included.
Statistical Analysis
All the clinical characteristics and neuroimaging findings listed in Table 1 were analyzed. Patient age was dichotomized at 20, 40, or 60 years old, and other continuous variables were dichotomized at their median values. Factors potentially affecting nidus obliteration were evaluated by performing the log-rank test for univariate analysis. For the multivariate analysis, a logistic regression model was used because the results of joint significance tests for five different models-the Cox proportional hazards model, an exponential regression model, the Weibull regression model, a log normal regression model, and a log logistic regression model-indicated that the logistic regression model was most suitable. The Mann-Whitney rank test and logistic regression models were used for analysis of factors associated with radiation-induced neuropathy and nidus obliteration occurring later than 3 years.
Results
The patients were followed up from 1 to 135 months (mean 63 months, median 65 months). Neuroimages spanning longer than 2 years of follow up were available in 351 patients (86%). The follow-up periods were discontinued before 2 years in 57 patients; 29 (7.1%) of these patients declined further neuroimaging examinations because cerebral angiography disclosed nidus obliteration earlier than 2 years and nine (2.2%) died before the 2-year follow-up examination (range of follow-up periods 1-19 months, median 6 months; six patients died of latency-interval hemorrhage and three of unrelated causes). The last neuroimaging follow-up period did not reach 2 years in the other 19 patients (4.7%).
Eight patients (2%) treated in our early experience were excluded from our analysis of the nidus obliteration rate because the radiation dose that was applied to the margins of the lesion (10-15 Gy, median 15 Gy) was lower than the current standard in those cases. The nidus obliteration rates after radiosurgery were therefore analyzed in 400 patients (98% of patients in whom the dose applied to the margin was 17-28 Gy [median 20 Gy]). The clinical characteristics of the patients and their neuroimaging findings at the time of radiosurgery are summarized in Table 1 .
Results of the Imaging Response
Follow-up cerebral angiography was performed in 320 patients (1-135 months after radiosurgery; angiographic follow ups ceased earlier than 2 years post-GKS in nine patients with residual AVMs) and obliteration of the nidus was confirmed in 260 patients (6-99 months after radiosurgery, median 23 months). In six patients, a neuroimaging examination was not performed periodically and obliteration of the nidus was not confirmed until longer than 5 years after radiosurgery. Follow-up data in these patients were excluded from the analysis because the elapsed time (in years) from radiosurgery to nidus obliteration was not clear. In 25 patients, the AVMs disappeared on angiograms later than 3 years after radiosurgery. In three of these patients, neuroimages obtained 4 years after radiosurgery demonstrated a residual nidus and nidus obliteration was not confirmed until later. Another 60 patients were followed up for 12 to 135 months (median 77 months) and the residual nidus was seen at the last follow-up examination. The neuroimages obtained 5 years after radiosurgery disclosed the presence of a residual nidus in 37 patients; additional follow up in those patients demonstrated no further reduction or obliteration of the nidus (Table 2 ).
Eighty patients were followed up using CT and MR imaging alone: 60 did not undergo cerebral angiography because the CT or MR images still disclosed a patent AVM nidus at their last follow-up examination and another 20 patients refused further examination by angiography after CT or MR images demonstrated no residual nidus. We were able to compare 130 CT scans and 214 MR images with cerebral angiograms that had been obtained almost simultaneously (at intervals of Ͻ 3 months; median interval 0 months; Table 3 ). A residual nidus was not detected on 85 CT scans or on 154 MR images; cerebral angiograms confirmed nidus obliteration in 74 cases (87.1%) in which CT scans were reviewed and in 123 cases (79.9%) in which MR images were reviewed. On the other hand, 45 CT scans and 60 MR images demonstrating a residual nidus were paired with angiograms that also demonstrated a residual nidus (100%). A discrepancy between angiography and CT or MR imaging results was found on 42 occasions. In all of these cases, angiography depicted a residual nidus that did not appear on CT or MR images.
There were 20 cases in which a CT or MR image demonstrated disappearance of the AVM but there was no angiographic confirmation. When these cases are counted as having complete obliteration of the nidus (the "best case scenario" in Table 4 ), the nidus obliteration rates are 73.5% at 3 years and 88.1% at 5 years. On the other hand, when these cases are counted as having a residual nidus, the nidus obliteration rates are 68.2% at 3 years and 81.7% after 5 years (the "worst case scenario" in Table 4 ).
Factors Associated With a Successful Nidus Obliteration
Using neuroimaging data for evaluation (findings on angiography and a residual nidus on CT or MR images), fac- * Numbers in parentheses represent patients in whom high-resolution thinslice CT or Gd-enhanced MR imaging was obtained in combination with angiography at dose planning.
† Patients with obliterated AVMs confirmed before the assigned time (year post-GKS).
‡ Patients with residual AVMs confirmed after the assigned time (year post-GKS).
§ Patients with AVMs who were followed up by CT or MR imaging alone.
tors associated with nidus obliteration were analyzed (Table  5 ). Factors significantly associated with a better obliteration rate in the univariate analysis were prior resection (p = 0.0038), hemorrhage before radiosurgery (p = 0.001), clearly disclosed nidus margin (p = 0.0066), maximum nidus diameter less than 3 cm (p = 0.0094), mean nidus diameter less than 1.5 cm (p Ͻ 0.0001), nidus volume less than 1.9 cm 3 (p Ͻ 0.0001), and radiosurgery in which the radiation dose directed to the margin was greater than 20 Gy (p Ͻ 0.0001) or at least 20 Gy (p = 0.0183). Endovascular embolization performed before radiosurgery had no correlation with the nidus obliteration rate in our results.
Five factors significant in the univariate analysis-prior resection, hemorrhage before radiosurgery, clearly disclosed nidus margin, mean nidus diameter, and marginal dose-were subjected to the multivariate analysis. Hemorrhage before radiosurgery (p = 0.0084), smaller nidus diameter (p = 0.0023), and higher dose to the margin (p = 0.0495) were also significantly associated with a better obliteration rate in the multivariate analysis.
Factors Associated With Earlier Nidus Obliteration
For the 254 patients in whom nidus obliteration was confirmed on angiograms, the intervals from radiosurgery to obliteration were evaluated (Table 6 ). In these 254 patients, nidus obliteration occurred within 3 years in 229 patients (90.2%). Factors associated with earlier nidus obliteration in the univariate testing were male sex (p = 0.0022), patient age younger than 20 years (p = 0.0113) and younger than 40 years (p = 0.0012), previous resection (p = 0.0413), hemorrhage before radiosurgery (p Ͻ 0.0001), deep venous drainage (p = 0.0059), dose planning performed using biplanar angiography alone (p = 0.0006), mean nidus diameter less than 1.5 cm (p = 0.0003), nidus volume less than 1.9 cm 3 (p = 0.0003), radiosurgery in which the margin dose is greater than 20 Gy (p = 0.0144), intraparenchymal nidus (nonsuperficial nidus, p = 0.023), and a clear nidus margin (p = 0.0122). Of these, male sex (p = 0.0001), hemorrhage before radiosurgery (p = 0.0039), smaller nidus diameter (p = 0.0006), and dose planning using biplanar angiography alone (p = 0.0201) were also significant in the multivariate analysis. Factors for nidus obliteration within 3 years were patient age younger than 40 years (p = 0.0007) and hemorrhage before radiosurgery (p = 0.0004), both of which were significant in the multivariate analysis (p = 0.0115 in both). In younger patients who underwent radiosurgery for their ruptured AVMs, obliteration of the AVM is expected within 3 years most frequently (Table 6 ).
Risks of Latency-Interval Hemorrhage
Before obliteration of the AVM nidus was confirmed by angiography, 21 patients experienced hemorrhage from the AVM nidus including three chronic expanding hematomas (range 0-123 months after radiosurgery, median 13 months). The annual bleeding rate was 1.9% and the cumulative risks of the latency-interval hemorrhage were 4.6% at 3 years, 10.2% at 5 years, and 14.6% at 10 years. In the univariate analysis, patient age older than 60 years (p = 0.0086), nidus location in the brainstem (p = 0.0025), nidus fed from perforating arteries of the basilar artery (p = 0.0002), cerebellar symptoms at radiosurgery (p = 0.0147), and subependymal nidus (p = 0.0153) were significant
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Obliteration rates after AVM radiosurgery † Assuming that all patients with nidus obliteration on CT or MR images had obliterated AVMs (number of all AVMs disappeared on angiography, CT, or MR images)/(number of all AVMs).
21
‡ Obliteration confirmed by angiography alone, but a residual lesion was confirmed by angiography, CT, or MR imaging (number of angiographically verified obliterated AVMs)/(number of AVMs examined with angiography ϩ number of residual lesions on CT or MR imaging).
§ Assuming that all patients followed up by CT or MR imaging alone had residual AVMs (number of angiographically obliterated AVMs)/(number of all AVMs). factors for a higher risk of latency-interval hemorrhage. Of those, patient age older than 60 years (p = 0.0188), nidus location in the brainstem (p = 0.0163), and subependymal nidus (p = 0.0321) were also significant in the multivariate analysis.
Results of Radiation-Induced Complications
Radiation-induced neurological deterioration was seen in 28 patients (6.9%) 1 to 33 months (median 11.5 months) following radiosurgery. In 22 patients, symptoms were mild and transient (worsening of existing symptoms: dysesthesia in six patients, hemiparesis in five, and aphasia in two; newly developed symptoms: dysesthesia in five patients, hemiparesis in two, and cranial nerve deficits in two) and lasted 2 to 23 months (median 5 months). The deteriorated neurological symptoms did not display any improvement in six patients (1.5%). Factors affecting neurological deterioration after radiosurgery were patient age older than 40 years (p = 0.0478), radiosurgery using a maximum dose greater than 40 Gy (p Ͻ 0.0001), nidus fed by the medial striate artery or by the artery of Heubner (p = 0.01), sensory disturbance at radiosurgery (p Ͻ 0.0001), and dose planning in which biplanar angiography was used alone (p = 0.0127). Among these factors, nidus fed by the medial striate artery or the artery of Heubner (p = 0.026), sensory disturbance at radiosurgery (p = 0.0103), and dose planning in which biplanar angiography was used alone (p = 0.0411) were significant factors for the multivariate analysis.
Discussion
Stereotactic radiosurgery has been performed in numerous patients with AVMs, and its efficacy has been demonstrated. 5, 10, 15, 18, 20, 28, 30, 38 Nevertheless, some essential questions have not yet been reasonably answered, such as whether we should calculate obliteration rates based on the findings of angiography alone or in combination with findings of CT or MR imaging, how effective it can be for patients with AVMs, or when we should conclude the initial treatment (after 3 years, 5 years, or even later). In this study, we have retrospectively analyzed our results of radiosurgery for AVMs so that we may rationally resolve these issues.
Definition of the Obliterated or Residual Nidus and the Obliteration Rates
Angiography can clearly visualize the hemodynamic status of an AVM and, therefore, disappearance of the nidus on angiography has been commonly accepted as evidence of nidus obliteration after AVM treatment. 5, 10, 18, 19, 20, 22, 23, 28, 30, 31, 38 The most reliable method to evaluate nidus obliteration following radiosurgery is to perform periodic cerebral angiography in all patients. In practice, however, some patients decline follow-up angiography or are reluctant to receive further treatment, especially when CT or MR images have clearly demonstrated a residual nidus.
Although CT and MR imaging are less invasive than angiography, 2 they provide false-negative results in the detection of a residual nidus, with a 17.6% chance that there still will be a residual nidus on angiography (Table 3) . 26 If such false-negative data are mixed with the data obtained from angiograms, the nidus obliteration rates are less reliable. When CT or MR images clearly demonstrate a residual nidus in numerous patients who decline follow-up angiography, exclusion of these data will lead to an overestimation of the obliteration rate. Our results indicated that high-resolution CT or MR imaging was highly reliable at detecting a residual nidus after radiosurgery; in our study these images demonstrated a 100% rate of agreement with angiography in detecting a residual nidus (Table 3) .
For accurate information about the outcomes of AVM radiosurgery, only reliable neuroimaging data should be used in calculating the obliteration rate. We therefore believe that obliteration rates should be calculated using the ratio of the number of cases with angiographically verified obliterated AVMs to the number of cases with angiographically examined AVMs plus the number of cases with residual AVMs on CT or MR images (obliteration rates using the evidential neuroimaging data shown in Table 4 , 87.3% at 5 years). Alternatively, the number of angiographically verified obliterated AVMs divided by the number of all AVMs with or without angiographic confirmation of obliteration would give a slightly conservative estimation (obliteration rates under the "worst case scenario" in Table 4 , 81.7% at 5 years).
Transition of Radiosurgical Techniques and Nidus Obliteration Rates
With the availability of CT or MR imaging, 3D dose planning was made possible, and the conformity and selectivity of the dosimetry were remarkably improved. 4, 9, 27, 32 This technical refinement contributed to an improvement in the overall nidus obliteration rate and a significant reduction in the risk of radiation-induced neurological complications. Nevertheless, our results show that dose planning with biplanar angiography alone (2D dose planning) was one of the significant factors associated with earlier nidus obliteration ( Table 6 ), indicating that the latency interval until nidus obliteration was prolonged after the technical refinements in dosimetry. In the 2D dose planning method, the whole nidus had to be covered extensively within the prescribed isodose line by estimating hidden parts of the lesion behind the projected images of biplanar angiograms. 9, 13, 35, 39 Therefore, in such cases, some parts of the nidus margin may have received a higher dose of radiation than that applied to the margin and this could have led to shorter latency intervals.
According to the literature, nidus obliteration rates are usually assessed at 3 years or earlier after radiosurgery 5, 10, 15, 18, 20, 30, 38 and are often compared with outcomes of other treatment modalities. 22, 23, 28, 31 In our study, the nidus obliteration rates in patients treated with the 3D dosimetry plan increased by 15% between 3 and 5 years. Therefore, the eventual rate of nidus obliteration after AVM radiosurgery also should be evaluated with data based on longer follow-up periods, 5 years after radiosurgery in some patients. The risk of experiencing a hemorrhage during the latency interval should also be evaluated for a longer time as well.
When the results of radiosurgery performed using 2D dose planning are compared with those performed using 3D planning, in the former nidus obliteration rates are apparently lower and risks of radiation-induced complications are remarkably higher. Also, using a higher margin dose with modern radiosurgical techniques, we can achieve the same latency intervals with much less risk of radiation-induced complications. Therefore, 2D dose planning should not be adopted nowadays.
Factors Associated With Better and Earlier Nidus Obliteration
Smaller nidus size, clearly depicted nidus margin, higher radiation dose to the margin, and a younger patient were previously reported to be associated with better obliteration rates after radiosurgery. 3, 5, 7, 10, 18, 24, 30 Statistical analysis in our series indicated that previous hemorrhage also was an important factor for better and earlier nidus obliteration (Tables 5 and 6 ). After GKS, ionizing radiation causes endothelial damage and proliferation of myofibroblasts, leading to the progressive occlusion of the internal lumen and shrinkage of the AVM nidus. 29, 36, 37 Spontaneous obliteration of an AVM is known as a rare phenomenon that occurs several months to years after hemorrhage, indicating that the endothelial damage caused by the hemorrhage promotes occlusion of the internal lumen and thrombosis of the AVMs. 11, 16, 21 Furthermore, myofibroblasts are known to appear after hemorrhage and accelerate arterial vasoconstriction after subarachnoid hemorrhage. 12, 33 The results of these previous studies support the rationale of our results. Although our results seem to be favorable for patients who eventually choose radiosurgery for the treatment of their ruptured AVMs, these lesions usually carry higher risks of bleeding for a few years after the first hemorrhage. 8 Application of radiosurgery for these AVMs should therefore be decided cautiously.
Patient age and sex were also associated with earlier nidus obliteration in our study (Table 6 ). Arteriovenous malformations are known to be nonstatic vascular lesions with an active angiogenesis or vascular remodeling; 1, 11 thus AVM vessels have a higher turnover of endothelial cells, especially in younger patients. 11 For this reason, younger patients are assumed to have better responses to radiation. Recently, a difference between the sexes in the response to radiosurgery was reported, in which a lower obliteration rate in female patients was asserted. 3, 7 The vascular protective effects of estrogen may be one possible explanation for such a difference, 3 although the effects of estrogen on the vasculature are still unclear and evidence to support this theory is very poor at present. Because there was no significant difference in the age of the patients and the size of the AVM between male and female patients in our study, this mechanism remains unclear.
When a neuroimaging examination disclosed a residual nidus following radiosurgery, we had to decide whether we should recommend an additional treatment immediately or wait for another year, despite the risk of hemorrhage during the extended latency interval. In our results, age less than 40 years and a history of hemorrhage before radiosurgery were the significant factors for nidus obliteration within 3 years (Table 6 ). Therefore, if follow-up angiograms obtained 3 years after radiosurgery should disclose a residual nidus, it would be reasonable to recommend immediate additional treatment for younger patients who had undergone radiosurgery for their small ruptured AVMs. Practically, the necessity and timing of the second radiosurgery are decided not only by these simple factors, but also by comprehensive consideration of the neurological status of the patient, the location of the residual nidus, the status of the surrounding brain, and the causes of the residual lesion. Nevertheless, our results have provided us with useful information to consider before deciding the indication for and timing of additional treatment in each patient.
Conclusions
Stereotactic radiosurgery is effective as an alternative treatment modality for AVMs, achieving more than 80% of the eventual nidus obliteration rate with minimum neurological complications. Recent advances in radiosurgical techniques have improved the conformity and selectivity of the dosimetry, but simultaneously they may have resulted in diverse latency intervals until obliteration of the AVM nidus. Final radiosurgical outcomes for AVMs therefore should be evaluated using data based on longer follow-up periods, and the risks of the latency-interval hemorrhage should be estimated and discussed with the patients accordingly. Decisions about treatment failure and the timing of additional treatments for the residual nidus should be made cautiously, taking into consideration the size of the nidus, the patient's sex and age, and the history of previous hemorrhage before radiosurgery.
